AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Senti Biosciences to Present at H.C. Wainwright Global Investment Conference
ByAinvest
Tuesday, Sep 2, 2025 9:11 am ET1min read
Senti Biosciences announced that Timothy Lu, CEO, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. Lu will discuss the company's Gene Circuit platform and its clinical-stage cell and gene therapies. The presentation will be available as a live webcast on Senti Bio's website, with a replay available for 90 days.
Senti Biosciences, Inc. (Nasdaq: SNTI), a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies, has announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference. The event will take place on September 8, 2025, in New York, NY, with a presentation by Co-Founder and CEO Dr. Timothy Lu scheduled for 2:00 PM ET.Dr. Lu will discuss Senti Biosciences' proprietary Gene Circuit platform and its clinical-stage cell and gene therapies. The Gene Circuit platform is designed to engineer new medicines with enhanced precision and control, capable of precisely killing cancer cells while sparing healthy cells and increasing specificity to target tissues. Senti Bio's pipeline includes cell therapies engineered with Gene Circuits to target challenging liquid and solid tumor indications. The platform has been shown preclinically to work in both NK and T cells and has demonstrated potential in other modalities and diseases outside of oncology.
In addition to the presentation, Senti Bio's management will be available for one-on-one meetings with qualified investors attending the conference. A live video webcast of the presentation will be available on Senti Bio's website, with a replay archived for 90 days following the event.
For more information about the conference, interested parties can visit the conference website. Additional information about Senti Bio can be found on the company's website, [Senti Bio](https://www.sentibio.com), or by following the company on X (@SentiBio) and LinkedIn (Senti Biosciences).
References:
[1] https://www.stocktitan.net/news/SNTI/senti-bio-to-present-at-the-h-c-wainwright-27th-annual-global-h01iszlz6505.html
[2] https://finance.yahoo.com/news/senti-bio-present-h-c-130500881.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet